Oculis Holding AG OCS

NAS: OCS | ISIN: CH1242303498   13/11/2024
14,72 USD (-1,80%)
(-1,80%)   13/11/2024

Oculis Publishes Consolidated Q2 Financial Statements and MD&A

ZUG, Switzerland, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Following the Company‘s press release published earlier today, the Q2 Consolidated Financial Statements and the MD&A, which have now been filed with the SEC on form 6-K, are attached.

Attachments


Mijn selecties